Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$10.37 USD
+0.59 (6.03%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $10.34 -0.03 (-0.29%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-1.08 | 0.00% |
Earnings Summary
For their last quarter, Inovio Pharmaceuticals (INO) reported earnings of -$1.08 per share, beating the Zacks Consensus Estimate of $-1.56 per share. This reflects a positive earnings surprise of 30.77%. Look out for INO's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$1.08 per share, reflecting a year-over-year increase of 43.75%.
Earnings History
Price & Consensus
Zacks News for INO
CymaBay Therapeutics Inc. (CBAY) Reports Q4 Loss, Misses Revenue Estimates
INO: What are Zacks experts saying now?
Zacks Private Portfolio Services